Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Abdominal Electromyographic Control in Vojta Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04818879
Recruitment Status : Completed
First Posted : March 26, 2021
Last Update Posted : September 29, 2021
Sponsor:
Collaborator:
Colegio Profesional de Fisioterapeutas de Castilla y León
Information provided by (Responsible Party):
Pérez-Robledo, Fátima, University of Salamanca

Brief Summary:
A randomized clinical trial on a cohort of healthy subjects of legal age, both sexes, recruited from the university community and who will be randomly distributed into two groups (experimental and control). The objective will be to determine the feasibility of the standardized intervention protocol on the stabilizing muscles of the trunk (external oblique and internal oblique) before, during and after the application of Vojta Therapy, and to know the effects produced on the Musculature studied after performing the intervention.

Condition or disease Intervention/treatment Phase
Abdominal Muscles Other: Vojta Other: Control Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Basic Science
Official Title: Electromyographic Response Control in the Application of Vojta Therapy in the Abdominal Muscles of Healthy Young Adults
Actual Study Start Date : April 1, 2021
Actual Primary Completion Date : April 30, 2021
Actual Study Completion Date : April 30, 2021

Arm Intervention/treatment
Experimental: Interventional group Other: Vojta

The subject will be placed on a stretcher with the torso uncovered. Once the adhesive electrodes have been placed in the different recording areas on the anterior part of the trunk, a recording of the activity at rest will begin, two minutes of stimulation (digital pressure), one minute of rest, two minutes of stimulation in the contralateral side and, finally, one minute of rest.

The therapy consists of the application of a stimulating pressure in the pectoral area in the pattern of the locomotion complex of reflex rolling in its first phase. For this, the subject will be placed in a supine position aligned with respect to the axial axis, with the arms along the body, the lower extremities in extension, and the head extended with a rotation of approximately 30º towards one side of the stimulation. The manual stimulation pressure will be exerted in the space between the 6th-7th or the 7th-8th rib under the mammillary line, with a force of about 2 kg.


Sham Comparator: Control group Other: Control

The subject will be placed on a stretcher with the torso uncovered. Once the adhesive electrodes have been placed in the different recording areas on the anterior part of the trunk, a recording of the activity at rest will begin, two minutes of stimulation (digital pressure), one minute of rest, two minutes of stimulation in the contralateral side and, finally, one minute of rest.

The control group will receive an application in an area with low receptor density located on the thigh, with a force of about 2 kg.





Primary Outcome Measures :
  1. Electromyographic activity in abdominal muscles [ Time Frame: Change from Baseline electromyographic activity at 7 minutes. ]
    The electromyographic activity of internal and external obliques in nanovolts will be collected before, during and after the intervention.


Secondary Outcome Measures :
  1. Date of birth [ Time Frame: Baseline ]
    It will be registered at the beginning of the study in order to calculate the age of the participant.

  2. Sex [ Time Frame: Baseline ]
    It will be registered at the beginning of the study.

  3. Height [ Time Frame: Baseline ]
    It will be registered at the beginning of the study in centimeters.

  4. Weight [ Time Frame: Baseline ]
    It will be registered at the beginning of the study in kilograms.

  5. International Physical Activity Questionnaire [ Time Frame: Baseline ]
    It will be measured at the beginning of the study to quantify the level of physical activity of the participant. This validated scale allows you to determine if you have a low, moderate or high physical level.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Over 18 years old.
  • Full cognitive capacity.

Exclusion Criteria:

  • Subjects with neuro-muscular pathologies that affect the abdominal muscles, previous surgeries in the area or any chronic neurological or organic disorder that may alter the results.
  • Vaccinated in the 10 days prior to the intervention
  • Fever

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04818879


Locations
Layout table for location information
Spain
Universidad de Salamanca
Salamanca, Spain, 37007
Sponsors and Collaborators
University of Salamanca
Colegio Profesional de Fisioterapeutas de Castilla y León
Investigators
Layout table for investigator information
Principal Investigator: Fátima Pérez-Robledo, PhD University of Salamanca
Layout table for additonal information
Responsible Party: Pérez-Robledo, Fátima, Professor, University of Salamanca
ClinicalTrials.gov Identifier: NCT04818879    
Other Study ID Numbers: NEUROUSAL04/2021
First Posted: March 26, 2021    Key Record Dates
Last Update Posted: September 29, 2021
Last Verified: September 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Pérez-Robledo, Fátima, University of Salamanca:
Electromyography
Abdominal Muscles
Muscle Contraction
Outcome and Process Assessment
Health Care